share_log

Bristol-Myers Squibb | 4: Statement of changes in beneficial ownership of securities-Officer Hickey Benjamin

SEC announcement ·  Mar 5 07:02
Summary by Futu AI
Bristol-Myers Squibb (BMY) has reported a transaction involving Benjamin Hickey, the President of RayzeBio Org., according to a recent filing. The transaction took place on March 1, 2024. However, the filing did not disclose specific details regarding the number of shares transacted, the nature of the shares, the transaction price, or the total value of the shares. Additionally, the number of shares held by Hickey after the transaction was not provided. This lack of detail in the report leaves investors without key information that could influence their investment decisions in Bristol-Myers Squibb stock.
Bristol-Myers Squibb (BMY) has reported a transaction involving Benjamin Hickey, the President of RayzeBio Org., according to a recent filing. The transaction took place on March 1, 2024. However, the filing did not disclose specific details regarding the number of shares transacted, the nature of the shares, the transaction price, or the total value of the shares. Additionally, the number of shares held by Hickey after the transaction was not provided. This lack of detail in the report leaves investors without key information that could influence their investment decisions in Bristol-Myers Squibb stock.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.